Cargando…
Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials
OBJECTIVES: This study aimed to evaluate any correlations between baseline creatinine clearance and the development of grade 3/4 toxicities during treatment within oncology phase I trials of molecularly targeted agents where entry criteria mandate a serum creatinine of ≤1.5 × the upper limit of norm...
Autores principales: | Basu, B., Vitfell-Pedersen, J., Moreno Garcia, V., Puglisi, M., Tjokrowidjaja, A., Shah, K., Malvankar, S., Anghan, B., de Bono, J.S., Kaye, S.B., Molife, L.R., Banerji, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079100/ https://www.ncbi.nlm.nih.gov/pubmed/22889980 http://dx.doi.org/10.1159/000341152 |
Ejemplares similares
-
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents
por: Moreno Garcia, V, et al.
Publicado: (2012) -
Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine
por: Wang, Sheng, et al.
Publicado: (2021) -
Validation of the Cockroft-Gault formula for estimation of creatinine clearance in the critically ill population
por: Kharbanda, M, et al.
Publicado: (2006) -
Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery
por: Walter, Jörg, et al.
Publicado: (2003) -
History of creatinine clearance: tribute to a forerunner
por: Losito, Attilio
Publicado: (2023)